Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000018658
JPRN-UMIN000018658
Completed
Phase 1

Phase I study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 and intraperitoneal infusion of nafamostat mesilate for gastric cancer with peritoneal dissemination - Phase I study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 and intraperitoneal infusion of nafamostat mesilate for gastric cancer with peritoneal dissemination

The Jikei University School of Medicine0 sites18 target enrollmentSeptember 1, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGastric cancer with peritoneal dissemination

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Gastric cancer with peritoneal dissemination
Sponsor
The Jikei University School of Medicine
Enrollment
18
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 1, 2015
End Date
March 29, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Metastasis to distant organ sites (such as the liver, lungs or bone), other active concomitant malignancies, or other severe medical conditions (such as pulmonary fibrosis, active infection, uncontrollable heart disease, uncontrollable diabetes mellitus, history of severe drug allergy).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Phase II study of intravenous and intraperitoneal paclitaxel combined with S-1 for gastric cancer with peritoneal metastasisgastric cancer with peritoneal metastasis
JPRN-UMIN000002850Department of Surgical Oncology, The University of Tokyo56
Recruiting
Phase 1
A Phase-I clinical study of intravenous AntiPlatelet, AntiCoagulant (APAC) in healthy subjects.
CTRI/2023/04/051500Cadila Pharmaceutical Limited
Completed
Phase 2
Feasibility study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced biliary tract cancer with carcinomatous ascites.Advanced biliary tract cancer with carcinomatous ascites
JPRN-UMIN000007520The University of Tokyo30
Completed
Not Applicable
Phase 1 clinical study of multiple intravenous doses of TRM-1106 in healthy Japanese adult meHealthy male subjects
JPRN-UMIN000005922Terumo Corporation20
Completed
Phase 2
The efficacy and the safety of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced pancreatic cancer with carcinomatous ascites.Advanced pancreatic cancer with carcinomatous ascites.
JPRN-UMIN000005306The University of Tokyo30